Re: ZCC relationship to ZEL!
|
4
|
Zenith Epigenetics
|
Apr 13, 2019 01:53PM
|
Value of the accumulated deficit - a question
|
3
|
Resverlogix Corp.
|
Apr 17, 2019 04:39PM
|
Re: Resverlogix’ BETonMACE Phase 3 Trial Successfully Reaches its Targeted 250 MACE Events
|
2
|
Resverlogix Corp.
|
Apr 18, 2019 02:55PM
|
Classifying/taxonomy mCRPC patients
|
4
|
Zenith Epigenetics
|
Apr 20, 2019 02:12PM
|
Re: Not quite a breakout yet....
|
3
|
Resverlogix Corp.
|
Apr 20, 2019 02:32PM
|
Re: Classifying/taxonomy mCRPC patients
|
2
|
Zenith Epigenetics
|
May 01, 2019 03:27PM
|
Re: And there's the news, 3 month loan extension....
|
4
|
Resverlogix Corp.
|
May 04, 2019 02:14PM
|
Re: HDL Functionality
|
2
|
Resverlogix Corp.
|
May 08, 2019 02:23PM
|
Re: HDL Functionality
|
3
|
Resverlogix Corp.
|
May 09, 2019 02:47PM
|
Sell Zenith Shares
|
1
|
Zenith Epigenetics
|
May 09, 2019 02:55PM
|
Re: kelsee
|
1
|
Resverlogix Corp.
|
May 22, 2019 04:48PM
|
Re: My estimate for Top Line Data Announcement...is a shocker!
|
4
|
Resverlogix Corp.
|
Jun 07, 2019 02:26PM
|
Re: My estimate for Top Line Data Announcement...is a shocker!
|
4
|
Resverlogix Corp.
|
Jun 08, 2019 12:56PM
|
Re: Insider activity, grants of rights and an option exercise at 75 cents
|
2
|
Resverlogix Corp.
|
Jun 17, 2019 01:33PM
|
Re: Zenith funding???
|
3
|
Zenith Epigenetics
|
Jun 17, 2019 01:57PM
|
Re: Insider activity, grants of rights and an option exercise at 75 cents
|
2
|
Resverlogix Corp.
|
Jun 18, 2019 11:58AM
|
Re: Zenith funding???
|
2
|
Zenith Epigenetics
|
Jun 18, 2019 12:19PM
|
Re: Wouldn’t the timing be great?
|
4
|
Zenith Epigenetics
|
Jun 18, 2019 12:36PM
|
Re: Why are you invested in RVX
|
4
|
Resverlogix Corp.
|
Jun 19, 2019 12:46PM
|
Re: Array and Zenith
|
4
|
Zenith Epigenetics
|
Jun 22, 2019 12:26PM
|